Literature DB >> 14554018

Solid-state analysis of the active pharmaceutical ingredient in drug products.

Ann W Newman1, Stephen R Byrn.   

Abstract

The solid form of a drug substance is important when developing a new chemical entity. The crystalline form used in development is significant based on possible manufacturability, solubility, bioavailability and stability differences between the solid forms. Regulatory issues require that the form present in a solid dosage form or liquids containing undissolved drug substance be identified. Drug product samples can be analyzed by a variety of techniques to determine the crystal form present or changes that occur during the manufacture of a drug product. The form present will affect development, regulatory and intellectual property issues.

Mesh:

Substances:

Year:  2003        PMID: 14554018     DOI: 10.1016/s1359-6446(03)02832-0

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  21 in total

1.  Understanding the Tabletability Differences between Indomethacin Polymorphs Using Powder Brillouin Light Scattering.

Authors:  Beth A Young; Dherya Bahl; Lewis L Stevens
Journal:  Pharm Res       Date:  2019-08-19       Impact factor: 4.200

2.  Parts per Million Powder X-ray Diffraction.

Authors:  Justin A Newman; Paul D Schmitt; Scott J Toth; Fengyuan Deng; Shijie Zhang; Garth J Simpson
Journal:  Anal Chem       Date:  2015-10-22       Impact factor: 6.986

3.  Rapid analysis of pharmaceutical drugs using LIBS coupled with multivariate analysis.

Authors:  P K Tiwari; S Awasthi; R Kumar; R K Anand; P K Rai; A K Rai
Journal:  Lasers Med Sci       Date:  2017-10-27       Impact factor: 3.161

4.  Spray drying tenofovir loaded mucoadhesive and pH-sensitive microspheres intended for HIV prevention.

Authors:  Tao Zhang; Chi Zhang; Vivek Agrahari; James B Murowchick; Nathan A Oyler; Bi-Botti C Youan
Journal:  Antiviral Res       Date:  2012-12-26       Impact factor: 5.970

5.  Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulation.

Authors:  Sari Airaksinen; Milja Karjalainen; Niina Kivikero; Sari Westermarck; Anna Shevchenko; Jukka Rantanen; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2005-10-06       Impact factor: 3.246

6.  Classification and Visualization of Physical and Chemical Properties of Falsified Medicines with Handheld Raman Spectroscopy and X-Ray Computed Tomography.

Authors:  Tomoko Kakio; Naoko Yoshida; Susan Macha; Kazunobu Moriguchi; Takashi Hiroshima; Yukihiro Ikeda; Hirohito Tsuboi; Kazuko Kimura
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

Review 7.  An overview of famotidine polymorphs: solid-state characteristics, thermodynamics, polymorphic transformation and quality control.

Authors:  Shan-Yang Lin
Journal:  Pharm Res       Date:  2014-03-01       Impact factor: 4.200

8.  Structural and Physicochemical Aspects of Dasatinib Hydrate and Anhydrate phases.

Authors:  Saikat Roy; Rosalynn Quiñones; Adam J Matzger
Journal:  Cryst Growth Des       Date:  2012-03-13       Impact factor: 4.076

9.  Depth profiling of compression-induced disorders and polymorphic transition on tablet surfaces with grazing incidence X-ray diffraction.

Authors:  Mikko Koivisto; Paula Heinänen; Veli Pekka Tanninen; Vesa-Pekka Lehto
Journal:  Pharm Res       Date:  2006-02-10       Impact factor: 4.200

Review 10.  Nanomedicine in pulmonary delivery.

Authors:  Heidi M Mansour; Yun-Seok Rhee; Xiao Wu
Journal:  Int J Nanomedicine       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.